Therapixel and Onsite Women’s Health Announce Partnership to Deploy MammoScreen® AI for Enhanced Breast Cancer Detection Across National Provider Network
Therapixel, creators of MammoScreen®, a leading artificial intelligence (AI) solution for breast cancer screening, today announced a strategic partnership with Onsite Women’s Health, one of the nation’s largest in-office breast health and imaging networks. Through this collaboration, Onsite will offer MammoScreen across…